FDA withdraws approval of two poultry drugs.
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002167:Campylobacter / Q000187:drug effects*; D002169:Campylobacter Infections / Q000188:drug therapy / Q000382:microbiology; D002645:Chickens; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000662:veterinary*; D024841:Fluoroquinolones; D005517:Foodborne Diseases / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D011201:Poultry Diseases / Q000188:drug therapy*; D014422:Turkeys; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D002939:Ciprofloxacin; C047224:sarafloxacin